Your Global Leader in Stem Cell Market Research
Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.
Jerusalem, Israel and New York, New York, July 10, 2017 — Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that Ronit Simantov, M.D. will join the Company as its new Chief Medical Officer (CMO) based in the U.S. [Read more…]
A growing phenomenon within the cord blood industry is the use of strategic alliances. This is not surprising, because it is valuable for cord blood banks to establish collaborative relationships with doctors, hospitals, birthing centers, insurance companies, government entities, medical researchers, public and private donors, and more. However, the terms and scope of key strategic alliances within the cord blood industry are often kept quiet. Other times, the partnerships are well-known within a specific region, but not publicized on a global basis.
For this reason, five key alliances that substantially impact the cord blood industry are explored below. [Read more…]
Miller Insurance Services
LLP was pleased to support and attend the recent meeting of the Cord Blood Association and representatives of European cord blood banks during the 3rd annual Cord Blood World Europe event hosted at the International Design Centre Islington. [Read more…]
On February 9, 2017, Upstate Cord Blood Bank in Syracuse, NY, opened its doors. The planning and construction was a lengthy process and cost $15 million.
The project origins go back to 2006 when the center was first proposed. Unfortunately, state funding for the project was delayed in 2008 due to economic conditions, and the build out of the cord blood bank was further delayed when design changes were implemented during construction. Senator John DeFrancisco had a pivotal role in securing state funding for the cord blood bank. [Read more…]
January 30, 2017, SAN ANTONIO – GenCure, a subsidiary of San Antonio-based biotech BioBridge Global, has entered a development and manufacturing agreement with stem cell technology developer StemBioSys Inc. of San Antonio. [Read more…]
